Eduardo Jose Matta MD, Presenter: Research Consultant, Pacific-Link Consulting

Venkateswar Rao Surabhi MD, Abstract Co-Author: Nothing to Disclose

Verghese George MBBS, Abstract Co-Author: Nothing to Disclose

Varaha Tammisetti MD, Abstract Co-Author: Nothing to Disclose

1. Review imaging characteristics of HCC on MDCT and DCE-MRI 2. Review HCC staging as it pertains to liver transplantation with attention 3. Categorize liver lesions according to OPTN/UNOS and LI-RADS criteria with special attention to new recommendations and policy changes 4. Correlate imaging characteristics to histopathologic samples 5. Describe imaging mimics and practical aids to accurately assessing for HCC

1. Relevance of HCC in cirrhosis and liver transplantation 1a. Staging 1b. MELD scoring and exceptions 2. Imaging technique for MDCT and DCE-MRI 3. HCC imaging features 4. Imaging standardization 4a. UNOS/OPTN categories and updates 4b. LI-RADS categories and updates 4c. Tools and templates 5. Histopathologic correlation (gross and microscopy) 6. Surgical and therapeutic considerations

http://abstract.rsna.org/uploads/2014/14009525/14009525_qsb1.pdf

Matta, E, Surabhi, V, George, V, Tammisetti, V, Update on Hepatocellular Carcinoma (HCC): Categorization and Histopathologic Correlation.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14009525.html